SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (3107)11/6/2000 8:22:05 PM
From: MichaelSkyy  Read Replies (2) of 5582
 
How's this, "Dipstick"..

Monday November 6, 8:04 pm Eastern Time
Press Release
SOURCE: Gum Tech International, Inc.
Gel Tech LLC Assures Consumers That Zicam(TM) Cold Remedy Does Not Contain PPA
WOODLAND HILLS, Calif., Nov. 6 /PRNewswire/ -- Gel Tech LLC, a joint venture between Gum Tech International, Inc., (Nasdaq: GUMM - news) and BioDelivery Technologies, Inc., today affirmed that Zicam(TM) Cold Remedy, a safe and effective over-the-counter homeopathic cold remedy, does not contain phenylpropanolamine (PPA).

The U.S. Food and Drug Administration issued a public health advisory today concerning PPA, which is found in many over-the-counter cough and cold medications and weight loss products. Zicam(TM) is not affected by this FDA announcement since it does not contain, and has never contained, the chemical PPA.

Zicam(TM) Cold Remedy uses a proprietary gel matrix to apply an emulsification of ionic zinc, known as Zinullose(TM), directly to the nasal cavity. In a study published in the October 2000 issue of the ENT -- Ear, Nose & Throat Journal, Zicam(TM) Cold Remedy was shown to reduce the duration of the common cold by an average of 75% when taken at the onset of symptoms.

Consumers with questions regarding Zicam(TM) should call toll-free 1-877-ZICAM-COLD or log onto www.zicam.com.

Zicam(TM) Cold Remedy was developed by Gel Tech, LLC, a joint venture between Gum Tech International, Inc. (Nasdaq: GUMM - news), a publicly held company located in Phoenix, AZ, and BioDelivery Technologies, Inc., a privately held biotechnology company. Gum Tech and BDT are engaged in the development of unique systems for delivering bioactive compounds.

SOURCE: Gum Tech International, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext